REFERENCES
1. Gregory EC, Valenzuela, Claudia P, Hoyert, Donna L. Fetal Mortality: United States, 2019. National Vital Statistics Reports. 2021;70(11).
2. Ptacek I, Sebire N, Man J, Brownbill P, Heazell A. Systematic review of placental pathology reported in association with stillbirth. Placenta. 2014;35(8):552-62.
3. Page JM, Christiansen-Lindquist L, Thorsten V, Parker CB, Reddy UM, Dudley DJ, et al. Diagnostic tests for evaluation of stillbirth: results from the Stillbirth Collaborative Research Network. Obstetrics & Gynecology. 2017;129(4):699-706.
4. Kidron D, Bernheim J, Aviram R. Placental findings contributing to fetal death, a study of 120 stillbirths between 23 and 40 weeks gestation. Placenta. 2009;30(8):700-4.
5. Pinar H, Goldenberg RL, Koch MA, Heim-Hall J, Hawkins HK, Shehata B, et al. Placental findings in singleton stillbirths. Obstetrics and gynecology. 2014;123(2 0 1):325.
6. Kulkarni VG, Sunilkumar KB, Nagaraj T, Uddin Z, Ahmed I, Hwang K, et al. Maternal and Fetal Vascular Lesions of Malperfusion in the Placentas Associated with Fetal and Neonatal Death: Results of a Prospective Observational Study. American journal of obstetrics and gynecology. 2021.
7. Ernst LM. Maternal vascular malperfusion of the placental bed. Apmis. 2018;126(7):551-60.
8. Mayhew TM, Charnock-Jones D, Kaufmann P. Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta. 2004;25(2-3):127-39.
9. Pinar H, Koch MA, Hawkins H, Heim-Hall J, Shehata B, Thorsten VR, et al. The Stillbirth Collaborative Research Network (SCRN) placental and umbilical cord examination protocol. American journal of perinatology. 2011;28(10):781.
10. Redline RW. Classification of placental lesions. American journal of obstetrics and gynecology. 2015;213(4):S21-S8.
11. Reddy UM, Page GP, Saade GR, Silver RM, Thorsten VR, Parker CB, et al. Karyotype versus microarray testing for genetic abnormalities after stillbirth. New England Journal of Medicine. 2012;367(23):2185-93.
12. Wapner RJ, Martin CL, Levy B, Ballif BC, Eng CM, Zachary JM, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. New England Journal of Medicine. 2012;367(23):2175-84.
13. Dhillon R, Hillman S, Morris R, McMullan D, Williams D, Coomarasamy A, et al. Additional information from chromosomal microarray analysis (CMA) over conventional karyotyping when diagnosing chromosomal abnormalities in miscarriage: A systematic review and meta‐analysis. BJOG: An International Journal of Obstetrics & Gynaecology. 2014;121(1):11-21.
14. Parker CB, Hogue CJ, Koch MA, Willinger M, Reddy UM, Thorsten VR, et al. Stillbirth Collaborative Research Network: design, methods and recruitment experience. Paediatric and perinatal epidemiology. 2011;25(5):425-35.
15. Dudley DJ, Goldenberg R, Conway D, Silver RM, Saade GR, Varner MW, et al. A new system for determining the causes of stillbirth. Obstetrics and gynecology. 2010;116(2 0 1).
16. Pinar H, Koch MA, Hawkins H, Heim-Hall J, Abramowsky CR, Thorsten VR, et al. The stillbirth collaborative research network postmortem examination protocol. American journal of perinatology. 2012;29(3):187.
17. Khong TY, Mooney EE, Ariel I, Balmus NC, Boyd TK, Brundler M-A, et al. Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus statement. Archives of pathology & laboratory medicine. 2016;140(7):698-713.
18. Khong TY, Mooney EE, Nikkels PG, Morgan TK, Gordijn SJ. Pathology of the placenta: a practical guide: Springer; 2019.
19. Kearney HM, Thorland EC, Brown KK, Quintero-Rivera F, South ST. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genetics in Medicine. 2011;13(7):680-5.
20. Pös O, Radvanszky J, Styk J, Pös Z, Buglyó G, Kajsik M, et al. Copy number variation: methods and clinical applications. Applied Sciences. 2021;11(2):819.
21. Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genetics in Medicine. 2020;22(2):245-57.
22. Gurbich TA, Ilinsky VV. ClassifyCNV: a tool for clinical annotation of copy-number variants. Scientific reports. 2020;10(1):1-7.
23. Pottinger TD, Puckelwartz MJ, Pesce LL, Robinson A, Kearns S, Pacheco JA, et al. Pathogenic and uncertain genetic variants have clinical cardiac correlates in diverse biobank participants. Journal of the American Heart Association. 2020;9(3):e013808.
24. Morales A, Hershberger RE. Variants of uncertain significance: should we revisit how they are evaluated and disclosed? : Am Heart Assoc; 2018. p. e002169.
25. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in medicine. 2015;17(5):405-23.
26. Korteweg FJ, Bouman K, Erwich JJH, Timmer A, Veeger NJ, Ravisé JM, et al. Cytogenetic analysis after evaluation of 750 fetal deaths: proposal for diagnostic workup. Obstetrics & Gynecology. 2008;111(4):865-74.
27. Reddy UM, Goldenberg R, Silver R, Smith GC, Pauli RM, Wapner RJ, et al. Stillbirth classification—developing an international consensus for research: executive summary of a National Institute of Child Health and Human Development workshop. Obstetrics and gynecology. 2009;114(4):901.
28. Wapner RJ, Lewis D. Genetics and metabolic causes of stillbirth. Seminars in perinatology; 2002: Elsevier; 2002. p. 70-4.
29. Burnside RD. 22q11. 21 deletion syndromes: a review of proximal, central, and distal deletions and their associated features. Cytogenetic and Genome Research. 2015;146(2):89-99.
30. Fulcheri E, Gualco M, Delfino F, Pantarotto M. Placental lesions in a case of DiGeorge sequence. Fetal diagnosis and therapy. 2006;21(1):1-7.
31. Zhang J, Zhang B, Liu T, Xie H, Zhai J. Partial trisomy 4q and monosomy 5p inherited from a maternal translocationt (4; 5)(q33; p15) in three adverse pregnancies. Molecular Cytogenetics. 2020;13(1):1-8.
32. Ramalingam A, Zhou X-G, Fiedler SD, Brawner SJ, Joyce JM, Liu H-Y, et al. 16p13. 11 duplication is a risk factor for a wide spectrum of neuropsychiatric disorders. Journal of human genetics. 2011;56(7):541-4.
33. Takeda N, Morita H, Fujita D, Inuzuka R, Taniguchi Y, Nawata K, et al. A deleterious MYH11 mutation causing familial thoracic aortic dissection. Human Genome Variation. 2015;2(1):1-3.
34. Guo D-C, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, Johnson RJ, et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. The American Journal of Human Genetics. 2009;84(5):617-27.
35. Mitchel MW, Moreno-De-Luca D, Myers SM, Levy RV, Turner S, Ledbetter DH, et al. 17q12 recurrent deletion syndrome. GeneReviews®[Internet]. 2020.
36. Verhave JC, Bech AP, Wetzels JF, Nijenhuis T. Hepatocyte nuclear factor 1β–associated kidney disease: more than renal cysts and diabetes. Journal of the American Society of Nephrology. 2016;27(2):345-53.
37. Miremberg H, Gindes L, Schreiber L, Raucher Sternfeld A, Bar J, Kovo M. The association between severe fetal congenital heart defects and placental vascular malperfusion lesions. Prenatal diagnosis. 2019;39(11):962-7.
38. Maslen CL. Recent Advances in Placenta–Heart Interactions. Frontiers in physiology. 2018;9:735.
39. Zun Z, Zaharchuk G, Andescavage NN, Donofrio MT, Limperopoulos C. Non-invasive placental perfusion imaging in pregnancies complicated by fetal heart disease using velocity-selective arterial spin labeled MRI. Scientific reports. 2017;7(1):1-10.
40. Araujo Junior E, Palma-Dias R, Martins W, Reidy K, da Silva Costa F. Congenital heart disease and adverse perinatal outcome in fetuses with confirmed isolated single functioning umbilical artery. Journal of Obstetrics and Gynaecology. 2015;35(1):85-7.
41. Del Gobbo GF, Konwar C, Robinson WP. The significance of the placental genome and methylome in fetal and maternal health. Human genetics. 2019:1-14.
42. Hemberger M, Hanna CW, Dean W. Mechanisms of early placental development in mouse and humans. Nature Reviews Genetics. 2020;21(1):27-43.
43. Denis M, Enquobahrie DA, Tadesse MG, Gelaye B, Sanchez SE, Salazar M, et al. Placental genome and maternal-placental genetic interactions: a genome-wide and candidate gene association study of placental abruption. PloS one. 2014;9(12):e116346.
44. Group SCRNW. Causes of death among stillbirths. Jama. 2011;306(22):2459.